[1]
2011. Palivizumab e virus respiratorio sinciziale: una panoramica. Farmeconomia. Health economics and therapeutic pathways. 12, 3S (Jul. 2011), 3–16. DOI:https://doi.org/10.7175/fe.v12i3S.984.